GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Qingdao Haier Biomedical Co Ltd (SHSE:688139) » Definitions » Capex-to-Operating-Income

Qingdao Haier Biomedical Co (SHSE:688139) Capex-to-Operating-Income : 0.28 (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Qingdao Haier Biomedical Co Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Qingdao Haier Biomedical Co's Capital Expenditure for the three months ended in Mar. 2024 was ¥-40.61 Mil. Its Operating Income for the three months ended in Mar. 2024 was ¥145.47 Mil.

Hence, Qingdao Haier Biomedical Co's Capex-to-Operating-Income for the three months ended in Mar. 2024 was 0.28.


Qingdao Haier Biomedical Co Capex-to-Operating-Income Historical Data

The historical data trend for Qingdao Haier Biomedical Co's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qingdao Haier Biomedical Co Capex-to-Operating-Income Chart

Qingdao Haier Biomedical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Operating-Income
Get a 7-Day Free Trial 0.81 0.28 0.44 0.50 0.52

Qingdao Haier Biomedical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.21 0.50 0.63 1.96 0.28

Competitive Comparison of Qingdao Haier Biomedical Co's Capex-to-Operating-Income

For the Medical Devices subindustry, Qingdao Haier Biomedical Co's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qingdao Haier Biomedical Co's Capex-to-Operating-Income Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Qingdao Haier Biomedical Co's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Qingdao Haier Biomedical Co's Capex-to-Operating-Income falls into.



Qingdao Haier Biomedical Co Capex-to-Operating-Income Calculation

Qingdao Haier Biomedical Co's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-177.181) / 343.067
=0.52

Qingdao Haier Biomedical Co's Capex-to-Operating-Income for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-40.613) / 145.469
=0.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qingdao Haier Biomedical Co  (SHSE:688139) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Qingdao Haier Biomedical Co Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Qingdao Haier Biomedical Co's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Qingdao Haier Biomedical Co (SHSE:688139) Business Description

Traded in Other Exchanges
N/A
Address
No.1 Haier Road, Branding Building, Qingdao, CHN, 266101
Qingdao Haier Biomedical Co Ltd is engaged in designing, manufacturing, marketing and sales of low temperature storage equipment for biomedical samples. The company provides provides complete storage solutions for biological sample banks, blood safety, vaccine safety, medical supplies and reagent safety.
Executives
Zhang Jiang Tao Core technical personnel
Liu Ji Yuan Core technical personnel
Teng Pei Kun Core technical personnel
Wang Guang Sheng senior management
Gong Yi Director
Huang Yan Li senior management
Chen Hai Tao Senior management, core technical personnel
Liu Zhan Jie Directors, senior managers, core technical personn
Mo Rui Juan senior management
Wang Wen Fu Director

Qingdao Haier Biomedical Co (SHSE:688139) Headlines

No Headlines